Cd44v6-derived peptides for treating pancreatic cancer

作者: Veronique Orian-Rousseau , Helmut Ponta , Alexandra Matzke

DOI:

关键词: OncologyInternal medicineMedicinePancreatic cancer

摘要: The present invention relates to compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.

参考文章(18)
Jiong Tao, Patrick Tan, Fusion genes in gastrointestinal cancer ,(2011)
Véronique Orian-Rousseau, Martina Tremmel, Helmut Ponta, Alexandra Matzke, Use of cd44v6 in the treatment of ophthalmic diseases ,(2010)
Véronique Orian-Rousseau, Alexandra Matzke, Christian Jung, Helmut Ponta, CD44v6 peptides as inhibitors of bacterial infections ,(2009)
Helmut Ponta, Wolfgang Rudy, Margot Zöller, Peter Herrlich, Martin Hofmann, Ursula Günthert, Cornelia Tölg, CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Research. ,vol. 51, pp. 5292- 5297 ,(1991)
Alexandra Matzke, Peter Herrlich, Helmut Ponta, Véronique Orian-Rousseau, A Five-Amino-Acid Peptide Blocks Met- and Ron-Dependent Cell Migration Cancer Research. ,vol. 65, pp. 6105- 6110 ,(2005) , 10.1158/0008-5472.CAN-05-0207
John Morrow Stewart, Solid Phase Peptide Synthesis ,(1984)
Toshirou Kawano, Shunsuke Yanoma, Yoshiyasu Nakamura, Osamu Shiono, Toshiyuki Kokatu, Akira Kubota, Madoka Furukawa, Mamoru Tsukuda, Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer American Journal of Otolaryngology. ,vol. 26, pp. 308- 313 ,(2005) , 10.1016/J.AMJOTO.2005.02.005